The role of capital

Access to capital plays a crucial role in creating world-class, innovation-led healthtech businesses.

Innovation needs to be funded in the right way at the right time so it can be scaled in a manner that most effectively captures the market opportunity.

This is especially true in healthtech, where the path to market is often more complex due to strict regulatory and clinical requirements and, typically, longer commercialisation pathways.

Importantly, raising capital isn’t only about gaining funding. The right investors can also bring new skills, experience and networks to your team – crucial for many healthtech ventures.

Where to start?

For many healthtech start-ups or entrepreneurs – especially those from clinical or research backgrounds – it’s not always clear where or how to begin when looking to raise capital, or what they need to do for a successful capital raise.

That’s why Callaghan Innovation created a library of Capital Education resources. Through a series of videos delivered by industry experts and a workshop to bring the learning together, the programme offers insights on everything from where to begin and how to identify (and avoid) critical fishhooks, to what investors want and how to pitch.

Find out what investors look for from Caroline Quay of Cure Kids Ventures, which invests in innovation with potential to benefit child health, for example. Or learn more about founder wellness from Marshall Couper, serial entrepreneur and CEO of mental health technology firm Loffty.

The HealthTech Activator is creating some sector-specific video podcasts to address the unique needs of healthtech when it comes to capital raising. You can watch them below.

Raising capital for healthtech
Covid-19 capital challenges for healthtech

Find out more

When looking to raise capital it’s important to understand the investment landscape and to stay up to date with market trends and issues related to healthtech.

Funding Explorer from Business.govt.nz is another great tool to help understand the funding sources that might be right for you – from bootstrapping or borrowing to a capital raise. Here are links to other helpful content:

Reports

Report

Winning in the future of medtech

Deloitte Insights, 2019
DOWNLOADRead More
Report

Global Healthcare Private Equity and Corporate M&A Report 2020

Bain & Company, 2020
DOWNLOADRead More
Report

Opportunities and challenges in an evolving market: 2020 healthcare and life sciences outlook

KPMG, 2020
DOWNLOADRead More
Report

Pulse of the industry 2019

EY, 2019
DOWNLOADRead More
Report

Pharma, Biotech & Medtech 2019 in review

Vantage / Evaluate, 2019
DOWNLOADRead More

Useful websites

Useful Website

MedTech Engine: MedTech Investors

DOWNLOADVisit website
Useful Website

Artesian Invest – Investing in the Future of Australia Medical Technology

DOWNLOADVisit website
Useful Website

Medtech Actuator

DOWNLOADVisit website
Useful Website

Artesian Invest – The Actuator MedTech VC Fund

DOWNLOADVisit website

Articles, commentary and blogs

Top 5: Healthcare venture capital funds Australia

doctology, December 2018
DOWNLOADRead More

Top 20 medical device venture capital firms

greenlight guru, November 2018
DOWNLOADRead More

Top 10 VCs investing in medical device companies

Vator.tv, October 2019
DOWNLOADRead More

Top MedTech Investors: A rapidly growing sector finds funding from venture partners

carevoyance, May 2019
DOWNLOADRead More

Deloitte: 'Medtech' firms of the future may forge novel partnerships with consumer tech to advance Data-driven health

prnewswire.com, September 2019
DOWNLOADRead More

Peregrine Ventures raises more than $115m MedTech fund

mobihealthnews.com, December 2019
DOWNLOADRead More

Sydney med-tech startup secures $3 million international investment

dynamicbusiness.com.au, February 2020
DOWNLOADRead More

How to cook up a successful medtech company

medicaldesignandoutsourcing.com, February 2020
DOWNLOADRead More

How are healthcare VCs in every sector handling Covid-19?

MedCityNews, March 2020
DOWNLOADRead More

Reimagining medtech for a COVID-19 world

McKinsey & Company, 22 April 2020
DOWNLOADRead More